You are here

  • Home
  • Archive
  • Volume 5, Issue Suppl 1
  • PS2:28 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events

Citation Tools

Article menu

Download PDFPDF

Poster session 2: Autoantibodies, biomarkers and imaging (2), Environmental, epigenetics and genomics
PS2:28 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Budde P, Marte J, Zucht H, et al
PS2:28 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events
Lupus Science & Medicine 2018;5:doi: 10.1136/lupus-2018-abstract.76